EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas

Yuki Saito, Hidenori Kage, Kenya Kobayashi iD, Masafumi Yoshida, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamasoba

Head & Neck · 2023

DOI: 10.1002/hed.27540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Yuki Saito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Otolaryngology, Head and Neck Surgery, University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Mouth Neoplasms, Carcinoma, Squamous Cell, Telomerase. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds The importance of TERT promoter ( pTERT ) mutation of oral cavity squamous cell carcinoma ( OCSCC ) with clinical features and genetic alterations are not well recognized.

Methods

We retrospectively analyzed genetic data from multiple databases, including 260 cases from the C‐CAT database, 407 cases from the MSK‐MetTropism database, and 40 OCSCC datasets from in‐house clinical samples.

Results

From C‐CAT database, TP53 (66%), CDKN2A (51%), and pTERT (29%) were the most frequent mutations observed. pTERT mutations were more prevalent in OCSCC (63%), younger individuals, and women (46%), with lower rates of alcohol abuse and smoking and co‐mutated with TP53, HRAS, and CASP8. MSK‐MetTroposim data validated with the enrichment of pTERT mutations in OCSCC, among women and Asian individuals. In‐house datasets OCSCC with pTERT mutation (50%) characterized by fewer recurrent neck metastases.

Conclusion

The study suggests that OCSCC with pTERT mutation represents a distinct subgroup with unique clinical and genetic characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsMouth NeoplasmsCarcinoma, Squamous CellTelomeraseHumansFemaleSquamous Cell Carcinoma of Head and NeckRetrospective StudiesMutation

Stichwörter der Autor:innen

HRASTERTgenetic profileyoung oral cancer

Substanzen

TERT protein, humanTelomerase

Autor:innen und Institutionen

  • Departments of Otolaryngology, Head and Neck Surgery, University of Tokyo, Tokyo, Japan.
  • Department of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Otolaryngology, Showa General Hospital, Tokyo, Japan.

ORCID-Profile: Kenya Kobayashi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Saito, Y., Kage, H., Kobayashi, K., Yoshida, M., Fukuoka, O., Yamamura, K., Mukai, T., Oda, K., & Yamasoba, T. (2023). TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas. Head & Neck. https://doi.org/10.1002/hed.27540

Vancouver

Saito Y, Kage H, Kobayashi K, Yoshida M, Fukuoka O, Yamamura K, et al. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas. Head & Neck. 2023. doi:10.1002/hed.27540

BibTeX
@article{Saito2023,
  author = {Saito, Yuki and Kage, Hidenori and Kobayashi, Kenya and Yoshida, Masafumi and Fukuoka, Osamu and Yamamura, Koji and Mukai, Toshiyuki and Oda, Katsutoshi and Yamasoba, Tatsuya},
  title = {TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27540}
}
Kostenlos starten →